Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 02 2020
Historique:
received: 15 11 2019
accepted: 05 12 2019
pubmed: 4 1 2020
medline: 4 9 2020
entrez: 4 1 2020
Statut: epublish

Résumé

Immunization with recombinant ALVAC/gp120 alum vaccine provided modest protection from human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) acquisition in humans and macaques. Vaccine-mediated protection was associated with the elicitation of IgG against the envelope V2 loop and of envelope-specific CD4

Identifiants

pubmed: 31896599
pii: JVI.01933-19
doi: 10.1128/JVI.01933-19
pmc: PMC7158742
pii:
doi:

Substances chimiques

AIDS Vaccines 0
ALVAC vaccine 0
HIV Envelope Protein gp120 0
Viral Vaccines 0
gp120 protein, Human immunodeficiency virus 1 0
CD40 Ligand 147205-72-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : THA-11906
Pays : Canada

Références

J Immunol. 2005 Sep 15;175(6):3502-7
pubmed: 16148092
PLoS One. 2014 Feb 04;9(2):e87572
pubmed: 24504509
Nat Med. 2016 Jul;22(7):762-70
pubmed: 27239761
J Virol. 2013 Sep;87(18):10163-72
pubmed: 23843636
Sci Transl Med. 2014 Mar 19;6(228):228ra39
pubmed: 24648342
Int Arch Allergy Immunol. 1997 Aug;113(4):393-9
pubmed: 9250584
J Immunol. 2018 Jan 1;200(1):286-294
pubmed: 29180488
Immunity. 1994 Jun;1(3):167-78
pubmed: 7534202
Clin Exp Immunol. 2014 Oct;178(1):102-11
pubmed: 24924152
J Virol. 2014 Sep 1;88(17):9579-89
pubmed: 24920805
Curr Protoc Immunol. 2005 Jan;Chapter 12:Unit 12.11
pubmed: 18432938
Immunol Invest. 1997 Jan-Feb;26(1-2):15-28
pubmed: 9037609
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51
pubmed: 1380261
AIDS Res Hum Retroviruses. 2012 Nov;28(11):1444-57
pubmed: 23035746
Cancer Immunol Immunother. 2012 Feb;61(2):255-263
pubmed: 22120756
J Virol. 2015 Apr;89(8):4690-5
pubmed: 25653428
J Virol. 2013 Mar;87(6):3538-48
pubmed: 23325681
Nature. 1998 Jun 4;393(6684):478-80
pubmed: 9624004
Front Immunol. 2019 May 14;10:1072
pubmed: 31139193
Front Immunol. 2018 Feb 26;9:348
pubmed: 29535724
J Immunol. 2015 Oct 1;195(7):3227-36
pubmed: 26297759
J Virol. 2008 Dec;82(24):12449-63
pubmed: 18842730
Annu Rev Med. 2015;66:423-37
pubmed: 25341006
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):393-400
pubmed: 21239998
Clin Infect Dis. 2014 Sep 15;59 Suppl 2:S80-4
pubmed: 25151483
J Virol. 2002 Jan;76(1):292-302
pubmed: 11739694
Nat Biotechnol. 2015 Jun;33(6):610-6
pubmed: 26006008
J Infect Dis. 2012 Aug 1;206(3):431-41
pubmed: 22634875
Cytometry A. 2012 May;81(5):360-1
pubmed: 22438313
Virology. 1990 Nov;179(1):247-66, 517-63
pubmed: 2219722
J Virol. 2006 Feb;80(4):1762-72
pubmed: 16439533
J Immunol. 2013 Mar 15;190(6):2495-9
pubmed: 23401588
Vaccine. 2010 Jul 12;28(31):5114-27
pubmed: 20471443
J Virol Methods. 2010 Feb;163(2):287-94
pubmed: 19878696
J Immunol. 2016 Oct 1;197(7):2726-37
pubmed: 27591322
AIDS. 1991 Jul;5(7):829-36
pubmed: 1716442
Lancet. 2015 Jul 11;386(9989):171-218
pubmed: 26117719
J Exp Med. 2009 May 11;206(5):1117-34
pubmed: 19414559
Vaccine. 1991 Mar;9(3):190-3
pubmed: 2042391
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):185-90
pubmed: 9874793
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
PLoS One. 2013 Sep 26;8(9):e75665
pubmed: 24086607
J Virol. 2015 Aug;89(16):8525-39
pubmed: 26041302
Oncoimmunology. 2013 Jan 1;2(1):e22546
pubmed: 23483661
Nat Med. 2018 Jun;24(6):847-856
pubmed: 29785023
Sci Transl Med. 2015 Jul 29;7(298):298ra120
pubmed: 26223303
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
J Virol. 2013 Feb;87(3):1708-19
pubmed: 23175374
J Virol. 2009 Feb;83(3):1216-27
pubmed: 19036823
AIDS. 2016 Jun 19;30(10):1521-1531
pubmed: 26959508
Clin Cancer Res. 2007 Feb 15;13(4):1083-8
pubmed: 17317815
J Exp Med. 1996 Aug 1;184(2):747-52
pubmed: 8760829
J Virol. 2013 Apr;87(8):4584-95
pubmed: 23408608
Virology. 1993 Aug;195(2):845-50
pubmed: 8337851
Immunol Lett. 2013 Jun;153(1-2):58-61
pubmed: 23892087
Hum Vaccin. 2010 Apr;6(4):355-9
pubmed: 20372075
Vaccine. 2008 Jul 29;26(32):4062-72
pubmed: 18562053
Circulation. 1999 Aug 10;100(6):614-20
pubmed: 10441098
Immunol Rev. 2009 May;229(1):152-72
pubmed: 19426221
J Virol. 2005 Aug;79(16):10108-25
pubmed: 16051804
J Immunol. 2012 May 15;188(10):5166-76
pubmed: 22529301
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):297-309
pubmed: 12787567
J Virol. 2014 Feb;88(3):1809-14
pubmed: 24257612
Vaccine. 2009 May 21;27(24):3165-74
pubmed: 19446187
J Exp Med. 2000 Feb 21;191(4):651-60
pubmed: 10684857
J Exp Med. 1968 Oct 1;128(4):801-20
pubmed: 5691985
Immunol Res. 2001;24(2):97-109
pubmed: 11594459
Lancet Infect Dis. 2012 Jul;12(7):531-7
pubmed: 22652344
Sci Transl Med. 2014 Mar 19;6(228):228ra38
pubmed: 24648341
J Clin Invest. 2002 Mar;109(5):613-20
pubmed: 11877469

Auteurs

Isabela Silva de Castro (I)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Shari N Gordon (SN)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Jun Liu (J)

Department of Medicine, University of Toronto, Toronto, Canada.
Keenan Research Center, St. Michael's Hospital, Toronto, Canada.

Massimiliano Bissa (M)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Katherine McKinnon (K)

Vaccine Branch Flow Cytometry Core, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Hung V Trinh (HV)

Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.

Melvin N Doster (MN)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Luca Schifanella (L)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Namal P Liyanage (NP)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

JinChao Cao (J)

Department of Medicine, University of Toronto, Toronto, Canada.
Keenan Research Center, St. Michael's Hospital, Toronto, Canada.

Olivia Cheng (O)

Department of Medicine, University of Toronto, Toronto, Canada.
Keenan Research Center, St. Michael's Hospital, Toronto, Canada.

Kathryn Foulds (K)

Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.

Mario Roederer (M)

Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.

Richard A Koup (RA)

Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.

Xiaoying Shen (X)

Department of Surgery, Duke Human Vaccine Institute, Durham, North Carolina, USA.

Georgia D Tomaras (GD)

Department of Surgery, Duke Human Vaccine Institute, Durham, North Carolina, USA.

David J Venzon (DJ)

Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Donald N Forthal (DN)

University of California, Irvine School of Medicine, Irvine, California, USA.

Timothy Fouts (T)

Advanced Bioscience Laboratories, Rockville, Maryland, USA.

David C Montefiori (DC)

Department of Surgery, Duke Human Vaccine Institute, Durham, North Carolina, USA.

Jim Tartaglia (J)

Sanofi Pasteur, Swiftwater, Pennsylvania, USA.

Mangala Rao (M)

Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.

Mario Ostrowski (M)

Department of Medicine, University of Toronto, Toronto, Canada.
Keenan Research Center, St. Michael's Hospital, Toronto, Canada.

Genoveffa Franchini (G)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA franchig@mail.nih.gov vaccarim@mail.nih.gov.

Monica Vaccari (M)

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA franchig@mail.nih.gov vaccarim@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH